Skip to content

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02073578
Acronym
POEM
Enrollment
20
Registered
2014-02-27
Start date
2012-08-31
Completion date
2014-12-31
Last updated
2021-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achalasia

Keywords

achalasia, POEM, peroral endoscopic myotomy, myotomy, Heller myotomy

Brief summary

This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be recruited for this trial, with the intent to treat 20 patients.

Detailed description

This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be recruited for this trial, with the intent to treat or attempt to treat 20 patients. Patients for whom a POEM has been attempted but not completed (conversion to open or laparoscopic surgery, POEM surgery aborted and not re-attempted). Patients who proceed to study treatment will undergo ten years of follow-up as part of this study.

Interventions

Endoscopy myotomy for treatment of achalasia

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Achalasia * Age 16-80 * ASA Class 1-3

Exclusion criteria

* Pregnancy * Any prior surgical or endoscopic treatment for achalasia -- first eight subjects. After eight subjects have been treated as part of this study, this

Design outcomes

Primary

MeasureTime frameDescription
Safety and Efficacy of POEM ProcedureIntraoperative to one year follow-upTo assess adverse events related to POEM
Long-term patient-reported quality of lifeBaseline to one year follow-upTo assess change in quality of life from baseline, based on validated quality of life measures, at baseline through 1 year follow-up.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026